These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23483875)

  • 1. Hormonal and cytokine implications in the pathophysiology of osteoporosis occurring in chronic liver diseases.
    Lucaci C; Acalovschi M
    Maedica (Bucur); 2012 Dec; 7(4):358-63. PubMed ID: 23483875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in chronic liver disease.
    Yadav A; Carey EJ
    Nutr Clin Pract; 2013 Feb; 28(1):52-64. PubMed ID: 23263929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of osteoporosis associated with liver disease.
    Nakchbandi IA; van der Merwe SW
    Nat Rev Gastroenterol Hepatol; 2009 Nov; 6(11):660-70. PubMed ID: 19881518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in chronic liver disease.
    Guañabens N; Parés A
    Liver Int; 2018 May; 38(5):776-785. PubMed ID: 29479832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis and its association with non-gonadal hormones involved in hypertension, adiposity and hyperglycaemia.
    Poudyal H; Brown L
    Curr Drug Targets; 2013 Dec; 14(14):1694-706. PubMed ID: 24060147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal alterations in PCOS and its influence on bone metabolism.
    Krishnan A; Muthusami S
    J Endocrinol; 2017 Feb; 232(2):R99-R113. PubMed ID: 27895088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
    Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
    J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report.
    Takeno A; Yamamoto M; Notsu M; Sugimoto T
    BMC Endocr Disord; 2016 Nov; 16(1):66. PubMed ID: 27881164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling.
    Galusca B; Bossu C; Germain N; Kadem M; Frere D; Lafage-Proust MH; Lang F; Estour B
    Osteoporos Int; 2006; 17(6):888-96. PubMed ID: 16541206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone cytokines.
    de Vernejoul MC; Cohen-Solal M; Orcel P
    Curr Opin Rheumatol; 1993 May; 5(3):332-8. PubMed ID: 8512770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal influences on osteoporosis.
    McKenna MJ; Frame B
    Am J Med; 1987 Jan; 82(1B):61-7. PubMed ID: 3544834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus a risk for osteoporosis?
    Leidig-Bruckner G; Ziegler R
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology of bone metabolism].
    Jakob F; Seefried L; Ebert R
    Internist (Berl); 2008 Oct; 49(10):1159-60, 1162, 1164 passim. PubMed ID: 18810375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.
    Zofková I
    Physiol Res; 2003; 52(6):657-79. PubMed ID: 14640888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation.
    Trautwein C; Possienke M; Schlitt HJ; Böker KH; Horn R; Raab R; Manns MP; Brabant G
    Am J Gastroenterol; 2000 Sep; 95(9):2343-51. PubMed ID: 11007240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Health in Patients With Liver Diseases.
    Danford CJ; Trivedi HD; Bonder A
    J Clin Densitom; 2020; 23(2):212-222. PubMed ID: 30744928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.
    Yilmaz Y
    Aliment Pharmacol Ther; 2012 Aug; 36(4):345-52. PubMed ID: 22730920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.